J&J knew about the asbestos contamination on its baby powder line but failed to notify the public and regulators. The company is facing another bout of inquiry from the U.S. Justice Department and Securities and Exchange Commission.
Public Health February 25, 2019
Johnson & Johnson became the first company to add pricing information on pharmaceutical products being advertised on television. The anticoagulant Xarelto will soon have a list price and out-of-pocket cost in commercials.
Public Health February 9, 2019
Johnson & Johnson is set to pay almost $26 million after a jury ruled in a talcum powder case. The complainant is diagnosed with mesothelioma, a deadly form of cancer that affects the lungs, heart, and stomach.
Public Health May 26, 2018
Stephen Lanzo claimed he contracted cancer after using Johnson & Johnson's products for more than 30 years. He and his wife were awarded $37 million in compensatory damages on Thursday.
Public Health April 7, 2018
A judge in Los Angeles has thrown out a $417 million 'talcum powder' case verdict against Johnson & Johnson. Previously, Johnson & Johnson was ordered to pay the sum to a woman who claimed she got ovarian cancer from the company's baby powder product.
Public Health October 21, 2017
Eva Echeverria claimed she would have stopped using Johnson & Johnson's talcum powder had a warning been placed on it. What do scientific studies say about the link between baby powder and ovarian cancer?
Public Health August 22, 2017
More than 700 women in Australia have filed a class action lawsuit against Johnson & Johnson over its vaginal mesh implants. The plaintiffs argued that the devices caused them to suffer excruciating and irreparable pain.
Public Health July 5, 2017
Invokana can significantly reduce heart events in type 2 diabetes patients but doubles risk for toe and lower foot amputations. How does Johnson & Johnson's Invokana fare compared with rival drug Jardiance?
Medicine June 13, 2017
Johnson & Johnson has lost another lawsuit connected to its cosmetic powders but the company continues to defend its products. Is it time to throw out talc-based products?
Public Health May 6, 2017
Johnson & Johnson was ordered to pay more than $110 million to a woman who claimed to have developed ovarian cancer after using the company's talc-based products for many years. What do studies say about the talcum powder and ovarian cancer link?
Public Health May 5, 2017
Johnson & Johnson and DePuy Orthopedics were ordered to pay $1.04 billion in compensatory and punitive damages to patients who were injured by the metal-on-metal Pinnacle hip implants. The amount is the third largest jury award of 2016.
Feature | Health December 1, 2016
A jury has awarded a California woman more than $70 million in a lawsuit that claims the use of Johnson & Johnson's baby powder caused her ovarian cancer. About 2,000 women have already filed similar suits that question the safety of the talcum powder.
Public Health October 28, 2016
Johnson & Johnson is facing a new lawsuit from a woman in California who claims the company's talcum powder has given her ovarian cancer. The company argues there is no scientific evidence to support the link.
Public Health September 27, 2016
J&J's subsidiary Acclarent pays $18 million in U.S. court settlement to resolve accusations related to an unapproved medical device. The marketing and distribution of said device resulted in false claims submitted to Medicare and other federal health programs.
Medicine July 25, 2016
Johnson & Johnson is facing about 1,200 lawsuits accusing it of ignoring studies that link its baby powder to ovarian cancer. The cases highlight the talc and ovarian cancer link - and how the company allegedly failed to warn consumers.
Healthy Living/Wellness May 4, 2016
Johnson & Johnson was ordered to pay damages to a South Dakota woman who developed ovarian cancer after decades of using the company's talc powder products. The company faces 1,200 other similar lawsuits.
Public Health May 2, 2016
The U.S. Food and Drug Administration has approved Johnson & Johnson's Remicade biosimilar, Inflectra. Now, doctors may prescribe this infliximab drug to patients.
Life April 6, 2016
European regulators on April 1 issued a conditional approval recommendation for the use of Johnson & Johnson's Darzalex in patients with blood cancer. The committee is awaiting more data from two ongoing studies.
Life April 3, 2016
Johnson & Johnson is in hot water after its baby products were linked to cancer.
Life February 26, 2016
A St. Louis jury ordered Johnson & Johnson to pay $72 million in damages to the family of a dead woman who used the company's talcum powder for several decades. What’s the link between talc and ovarian cancer?
Life February 25, 2016
An FDA advisory panel approved a knockoff arthritis drug called Remsima from Pfizer Inc. and Celltrion Inc. The drug is the biosimilar version of Amgen's Remicade, which has brought billions of profits for the company.
Life February 10, 2016
Eli Lilly's new diabetes treatment Jardiance stole market share from its rivals. The increased market share of 25 percent of new U.S. patients was attributed to clinical trial data showing fewer deaths among type 2 diabetics by 32 percent.
Life January 7, 2016
Newly approved multiple myeloma drug Darzalex offers hope for patients whose prior treatments failed to deliver results. The drug binds to proteins in tumor cells causing them to die and leaving healthy cells unharmed.
Life November 17, 2015
A combination drug from Johnson & Johnson and ViiV Healthcare showed promising results in suppressing HIV in a clinical trial. Initial results showed the long-lasting injectable drugs can suppress the virus when taken regularly.
Life November 4, 2015
The EBOVAC-Salone study will evaluate the efficacy and safety of Johnson & Johnson's experimental Ebola vaccine. The clinical trial will take place in Sierra Leone's Kambia district.
Life October 9, 2015
Who gets what and when? Johnson & Johnson is getting some help from ethicists regarding decisions about requests for compassionate use of investigational medicines.
Life May 8, 2015
IBM partners with Apple, Johnson & Johnson and Medtronics to boost Watson Health Cloud capabilities, taking advantage of personalized information to improve how health care is delivered to patients.
Life April 14, 2015
Google has partnered with Johnson & Johnson to develop and build surgical robots in order to offer surgeons more options and precision in surgery. The terms of the agreement have not yet been disclosed.
FUTURE TECH March 28, 2015
Johnson & Johnson subsidiary will pay $25 million to settle a suit over children's medications contaminated in faulty manufacturing. Infants' Tylenol and Children's Motrin were both subjects of recall in 2010.
Life March 11, 2015
Boston Scientific has been in a lot of hot water since it acquired Guidant in 2006. With this settlement, it is finally making peace with Johnson & Johnson and moving on.
Life February 20, 2015
Johnson & Johnson has received $115 to speed development of a vaccine for Ebola. Where do we currently stand in our fight against the disease?
Life January 16, 2015
Following warning from the FDA of the risks associated with laparoscopic power morcellation in removing fibroids, Johnson & Johnson pulled out its power morcellators worldwide albeit temporarily.
Life April 30, 2014
The FDA didn't show any love for Johnson & Johnson on Friday, Feb. 14, denying the pharmaceutical major's application for the expanded use of the anticoagulant drug Xarelto for the third time.
Life February 17, 2014